Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference63 articles.
1. PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside;Alzahrani;Semin. Cancer Biol.,2019
2. Searching Online Mendelian Inheritance in Man (OMIM): A Knowledgebase of Human Genes and Genetic Phenotypes;Amberger;Curr. Protoc. Bioinf.,2017
3. Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions;Ashkenazi;J. Clin. Invest.,2015
4. Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers;Ayoub;Ther. Adv. Med. Oncol.,2019
5. Cryptotanshinone ameliorates renal ischaemia-reperfusion injury by inhibiting apoptosis and inflammatory response;Bai;Basic Clin. Pharmacol. Toxicol.,2019
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In vitro and vivo anti-tumor activity and mechanisms of the new cryptotanshinone derivative 11 against hepatocellular carcinoma;European Journal of Pharmacology;2024-05
2. Cryptotanshinone suppresses ovarian cancer via simultaneous inhibition of glycolysis and oxidative phosphorylation;Biomedicine & Pharmacotherapy;2024-01
3. Prospective pharmacological potential of cryptotanshinone in cancer therapy;Pharmacological Research - Modern Chinese Medicine;2023-12
4. Upper-critical solution temperature (UCST) polymer functionalized nanomedicine for controlled drug release and hypoxia alleviation in hepatocellular carcinoma therapy;PLOS ONE;2023-08-25
5. Rational targeting of autophagy in colorectal cancer therapy: From molecular interactions to pharmacological compounds;Environmental Research;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3